Comparable drug levels and immunogenicity in patients with axial spondyloarthritis treated with adalimumab originator and biosimilar: A retrospective study from two centers of China.

Saved in:
Bibliographic Details
Title: Comparable drug levels and immunogenicity in patients with axial spondyloarthritis treated with adalimumab originator and biosimilar: A retrospective study from two centers of China.
Authors: Fu ZC; Division of Rheumatology, Department of Medicine, The Third Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China., Cheng XG; Department of Pharmacy, The Third Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China., Zhang GW; Department of Pathological Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China., Shi RG; Division of Rheumatology, Department of Medicine, The Third Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China., Zhang LJ; Department of Pathological Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China., Sun HT; Special Inspection Project Department, Guangzhou Huayin Medical Examination Center, Guangzhou, Guangdong, China., Huang JX; Division of Rheumatology, Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China.
Source: International journal of rheumatic diseases [Int J Rheum Dis] 2024 May; Vol. 27 (5), pp. e15190.
Publication Type: Letter; Multicenter Study; Comparative Study
Journal Info: Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model: Print Cited Medium: Internet ISSN: 1756-185X (Electronic) Linking ISSN: 17561841 NLM ISO Abbreviation: Int J Rheum Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1756-185X
DOI:10.1111/1756-185X.15190